HANY S SALAMA

Allopathic & Osteopathic Physicians|Internal Medicine SAINT LOUIS, MO NPI 1619064656

General Payments — all program years on this page

$3,875.95

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 256
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $336.10 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $336.1018

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $79.454
Teva Pharmaceuticals USA, Inc. $59.823
ABBVIE INC. $38.502
ITI, Inc. $37.272
OptiNose US, Inc. $23.141
Acerta Pharma LLC $19.101
Axsome Therapeutics, Inc. $18.081
PFIZER INC. $16.481
GlaxoSmithKline, LLC. $15.611
Amgen Inc. $14.571
Lundbeck LLC $14.081

By program year

Program yearAmountRecords
2018 $545.5647
2019 $450.9134
2020 $513.8839
2021 $714.8552
2022 $626.1233
2023 $688.5333
2024 $336.1018

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104372847 AstraZeneca Pharmaceuticals LP $19.10 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106003471 ABBVIE INC. $17.01 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106003473 ABBVIE INC. $21.49 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116491603 GlaxoSmithKline, LLC. $15.61 02/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117372438 Amgen Inc. $14.57 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131718501 PFIZER INC. $16.48 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134997602 Lilly USA, LLC $24.41 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134997604 Lilly USA, LLC $25.54 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135020066 Lilly USA, LLC $14.09 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135020068 Lilly USA, LLC $15.41 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142183016 Optinose US, Inc. $23.14 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143312188 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.69 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143312192 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.58 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145964388 Lundbeck LLC $14.08 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148283907 Axsome Therapeutics, Inc. $18.08 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151596482 Teva Pharmaceuticals USA, Inc. $19.71 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151596502 Teva Pharmaceuticals USA, Inc. $16.49 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151596572 Teva Pharmaceuticals USA, Inc. $23.62 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.